Silvia Marsoni Selected Research

Silvia Marsoni Research Topics

Disease

34	Neoplasms (Cancer) 02/2024 - 01/2003
31	Colorectal Neoplasms (Colorectal Cancer) 02/2024 - 11/2011
6	Colonic Neoplasms (Colon Cancer) 11/2021 - 05/2004
6	Disease Progression 12/2020 - 05/2012
5	Carcinoma (Carcinomatosis) 01/2020 - 01/2003
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 10/2011
3	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2020
3	Ovarian Neoplasms (Ovarian Cancer) 06/2012 - 03/2005
2	Diarrhea 01/2021 - 08/2013
2	Vomiting 01/2021 - 08/2013
2	Thrombocytopenia (Thrombopenia) 01/2021 - 08/2013
2	Stomach Neoplasms (Stomach Cancer) 01/2021 - 11/2019
2	Neutropenia 01/2021 - 03/2005
2	Nausea 01/2021 - 08/2013
2	Melanoma (Melanoma, Malignant) 01/2021 - 01/2020
2	Lung Neoplasms (Lung Cancer) 01/2019 - 01/2018
2	Exanthema (Rash) 06/2016 - 04/2010
2	Asthenia 09/2013 - 03/2005
2	Microsatellite Instability 06/2011 - 07/2010
2	Breast Neoplasms (Breast Cancer) 01/2011 - 06/2010
1	Turcot syndrome 01/2022
1	Stomatitis 01/2021
1	Adenocarcinoma 01/2021
1	Anemia 01/2021
1	Leukopenia 01/2021
1	Rectal Neoplasms (Rectal Cancer) 01/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Residual Neoplasm 09/2017
1	Fatigue 06/2016
1	Mesothelioma 04/2015
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 08/2013
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 08/2013
1	Multiple Myeloma 01/2013

Drug/Important Bio-Agent (IBA)

9	ErbB Receptors (EGF Receptor)IBA 01/2022 - 04/2010
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2011
6	Trastuzumab (Herceptin)FDA Link 01/2021 - 11/2015
6	Lapatinib (GW572016)FDA Link 01/2021 - 11/2015
6	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 05/2004
6	Cetuximab (Erbitux)FDA Link 01/2018 - 11/2011
5	Proteins (Proteins, Gene)FDA Link 02/2024 - 06/2011
5	Panitumumab (Vectibix)FDA Link 01/2022 - 07/2015
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2018
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2022 - 01/2020
4	Monoclonal AntibodiesIBA 01/2022 - 04/2010
4	PlatinumIBA 10/2015 - 03/2005
3	Circulating Tumor DNAIBA 11/2023 - 07/2015
3	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2019
3	pertuzumabIBA 01/2021 - 01/2020
3	Capecitabine (Xeloda)FDA Link 01/2021 - 10/2010
3	AntibodiesIBA 01/2019 - 11/2011
2	Calcibiotic Root Canal SealerIBA 01/2023 - 07/2015
2	Temozolomide (Temodar)FDA LinkGeneric 01/2022 - 12/2017
2	Sodium Glutamate (Accent)IBA 11/2021 - 01/2021
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2018 - 09/2013
2	Proteasome InhibitorsIBA 01/2013 - 06/2012
2	taxaneIBA 06/2012 - 03/2005
1	Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA 02/2024
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Thioguanine (Tioguanine)FDA Link 01/2023
1	Cancer VaccinesIBA 01/2023
1	pembrolizumabIBA 01/2022
1	viral interferon regulatory factorsIBA 10/2021
1	Everolimus FDA Link 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	olaparibIBA 01/2020
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020
1	sotorasibIBA 01/2020
1	trastuzumab deruxtecanIBA 01/2020
1	Ado-Trastuzumab EmtansineIBA 01/2020
1	Immunoconjugates (Immunoconjugate)IBA 01/2020
1	Amyloid (Amyloid Fibrils)IBA 01/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2020
1	Pregnenolone Carbonitrile (PCN)IBA 01/2019
1	regorafenibIBA 01/2019
1	human ERBB2 proteinIBA 01/2018
1	Cell-Free Nucleic AcidsIBA 09/2017
1	BilirubinIBA 06/2016
1	Codon (Codons)IBA 06/2016
1	Vorinostat FDA Link 04/2015
1	Docetaxel (Taxotere)FDA Link 09/2013
1	PanobinostatIBA 08/2013
1	Histone Deacetylase InhibitorsIBA 08/2013
1	Peptides (Polypeptides)IBA 01/2013
1	Boronic AcidsIBA 01/2013
1	delanzomibIBA 01/2013
1	liposomal doxorubicin (Doxil)FDA Link 06/2012
1	Bortezomib (Velcade)FDA Link 06/2012

Therapy/Procedure

19	Therapeutics 01/2023 - 04/2010
8	Drug Therapy (Chemotherapy) 01/2022 - 01/2003
3	Retreatment 11/2023 - 02/2019
3	Precision Medicine 11/2019 - 01/2011
2	Continuity of Patient Care 11/2023 - 01/2023
2	Immunotherapy 01/2022 - 02/2019
2	Adjuvant Chemotherapy 01/2021 - 05/2004
2	Aftercare (After-Treatment) 01/2019 - 03/2005
2	Neoadjuvant Therapy 01/2011 - 06/2010
1	Secondary Prevention 01/2023
1	Intravenous Administration 01/2013